Links between Schwann cells and melanocytes in development and disease

Pigment Cell and Melanoma Research

Volumn 26, Issue 5, 2013, Pages 634-645

  Van Raamsdonk, Catherine D ^a   Deo, Mugdha ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Carney complex; Desmoplastic melanoma; Melanocytes; NF1; Schwann cells

Indexed keywords

ADAM PROTEIN; B RAF KINASE; BETA CATENIN; DOPACHROME TAUTOMERASE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR 3; EPIDERMAL GROWTH FACTOR RECEPTOR 4; GLYCOPROTEIN GP 100; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; MYELIN; MYELIN BASIC PROTEIN; NERVE CELL ADHESION MOLECULE; NEU DIFFERENTIATION FACTOR; NEUROFIBROMIN; PERIPHERIN; PROTEOLIPID PROTEIN; PROTEOLIPID PROTEIN 1; STEM CELL FACTOR; TAMOXIFEN; TESTIS DETERMINING FACTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PAX3; TRANSCRIPTION FACTOR SOX10; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; CELL DIFFERENTIATION; CELL FATE; CELL FUNCTION; CELL MATURATION; CELL MIGRATION; CELL PROLIFERATION; CELL TRANSFORMATION; CENTRAL NERVOUS SYSTEM; DERMIS; DESMOPLASTIC MELANOMA; EPIDERMIS; GENE MUTATION; GENE REPRESSION; HISTOPATHOLOGY; HUMAN; IMMUNOREACTIVITY; MELANOCYTE; MELANOSIS; MELANOTIC SCHWANNOMA; NERVE CELL NETWORK; NERVE PROJECTION; NEURAL CREST CELL; NEURAL TUBE; NEURILEMOMA; NEUROFIBROMATOSIS; NEUROFIBROMATOSIS TYPE 1; NONHUMAN; PERIPHERAL NERVE; PERIPHERAL NERVOUS SYSTEM; PROMOTER REGION; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; REVIEW; SCHWANN CELL; SCLEROTOME; SOMITE; SPINAL GANGLION; SPINAL NERVE; TUMOR VOLUME; ZEBRA FISH;

MAMMALIA;

CARNEY COMPLEX; DESMOPLASTIC MELANOMA; MELANOCYTES; NF1; SCHWANN CELLS;

ANIMALS; CELL LINEAGE; DISEASE; GROWTH AND DEVELOPMENT; HUMANS; MELANOCYTES; SCHWANN CELLS;

EID: 84882827932     PISSN: 17551471     EISSN: 1755148X     Source Type: Journal    
DOI: 10.1111/pcmr.12134     Document Type: Review

References (131)

1. Adameyko, I., Lallemend, F., Aquino, J.B. et al. (2009). Schwann cell precursors from nerve innervation are a cellular origin of melanocytes in skin. Cell 139, 366-379.
2. Adameyko, I., Lallemend, F., Furlan, A. et al. (2012). Sox2 and Mitf cross-regulatory interactions consolidate progenitor and melanocyte lineages in the cranial neural crest. Development 139, 397-410.
3. Adilakshmi, T., Ness-Myers, J., Madrid-Aliste, C., Fiser, A., and Tapinos, N. (2011). A nuclear variant of ErbB3 receptor tyrosine kinase regulates ezrin distribution and Schwann cell myelination. J. Neurosci. 31, 5106-5119.
4. Arvanitis, L.D. (2010). Melanotic schwannoma: a case with strong CD34 expression, with histogenetic implications. Pathol. Res. Pract. 206, 716-719.
5. Birchmeier, C., and Nave, K.A. (2008). Neuregulin-1, a key axonal signal that drives Schwann cell growth and differentiation. Glia 56, 1491-1497.
6. Bitgood, M.J., and McMahon, A.P. (1995). Hedgehog and Bmp genes are coexpressed at many diverse sites of cell-cell interaction in the mouse embryo. Dev. Biol. 172, 126-138.
7. Bonaventure, J., Domingues, M.J., and Larue, L. (2013). Cellular and molecular mechanisms controlling the migration of melanocytes and melanoma cells. Pigment Cell Melanoma Res. 26, 316-325.
8. Bondurand, N., Pingault, V., Goerich, D.E., Lemort, N., Sock, E., Le Caignec, C., Wegner, M., and Goossens, M. (2000). Interaction among SOX10, PAX3 and MITF, three genes altered in Waardenburg syndrome. Hum. Mol. Genet. 9, 1907-1917.
9. Bossis, I., Voutetakis, A., Matyakhina, L. et al. (2004). A pleiomorphic GH pituitary adenoma from a Carney complex patient displays universal allelic loss at the protein kinase A regulatory subunit 1A (PRKARIA) locus. J. Med. Genet. 41, 596-600.
10. Boyle, J.L., Haupt, H.M., Stern, J.B., and Multhaupt, H.A. (2002). Tyrosinase expression in malignant melanoma, desmoplastic melanoma, and peripheral nerve tumors. Arch. Pathol. Lab. Med. 126, 816-822.
11. Bremer, M., Frob, F., Kichko, T., Reeh, P., Tamm, E.R., Suter, U., and Wegner, M. (2011). Sox10 is required for Schwann-cell homeostasis and myelin maintenance in the adult peripheral nerve. Glia 59, 1022-1032.
12. Britsch, S., Goerich, D.E., Riethmacher, D., Peirano, R.I., Rossner, M., Nave, K.A., Birchmeier, C., and Wegner, M. (2001). The transcription factor Sox10 is a key regulator of peripheral glial development. Genes Dev. 15, 66-78.
13. Buac, K., Xu, M., Cronin, J., Weeraratna, A.T., Hewitt, S.M., and Pavan, W.J. (2009). NRG1/ERBB3 signaling in melanocyte development and melanoma: inhibition of differentiation and promotion of proliferation. Pigment Cell Melanoma Res. 22, 773-784.
14. Carbonell, A.L., Boya, J., and Garcia-Maurino, J.E. (1992). Presence of melanin in normal human Schwann cells. Histol. Histopathol. 7, 329-332.
15. Carney, J.A. (1990). Psammomatous melanotic schwannoma. A distinctive, heritable tumor with special associations, including cardiac myxoma and the Cushing syndrome. Am. J. Surg. Pathol. 14, 206-222.
16. Casey, M., Vaughan, C.J., He, J., Hatcher, C.J., Winter, J.M., Weremowicz, S., Montgomery, K., Kucherlapati, R., Morton, C.C., and Basson, C.T. (2000). Mutations in the protein kinase A R1alpha regulatory subunit cause familial cardiac myxomas and Carney complex. J. Clin. Invest. 106, R31-R38.
17. Chambers, I., and Tomlinson, S.R. (2009). The transcriptional foundation of pluripotency. Development 136, 2311-2322.
18. Chen, L.L., Jaimes, N., Barker, C.A., Busam, K.J., and Marghoob, A.A. (2013). Desmoplastic melanoma: a review. J. Am. Acad. Dermatol. 68, 825-833.
19. Chetty, R., Vajpeyi, R., and Penwick, J.L. (2007). Psammomatous melanotic schwannoma presenting as colonic polyps. Virchows Arch. 451, 717-720.
20. Choi, W., Wolber, R., Gerwat, W., Mann, T., Batzer, J., Smuda, C., Liu, H., Kolbe, L., and Hearing, V.J. (2010). The fibroblast-derived paracrine factor neuregulin-1 has a novel role in regulating the constitutive color and melanocyte function in human skin. J. Cell Sci. 123, 3102-3111.
21. Cohen, C., Turner, M.L., and Stratakis, C.A. (2000). Pigmented lesions of the conjunctiva in Carney's complex. J. Am. Acad. Dermatol. 42, 145.
22. Curran, K., Lister, J.A., Kunkel, G.R., Prendergast, A., Parichy, D.M., and Raible, D.W. (2010). Interplay between Foxd3 and Mitf regulates cell fate plasticity in the zebrafish neural crest. Dev. Biol. 344, 107-118.
23. Danielian, P.S., Muccino, D., Rowitch, D.H., Michael, S.K., and McMahon, A.P. (1998). Modification of gene activity in mouse embryos in utero by a tamoxifen-inducible form of Cre recombinase. Curr. Biol. 8, 1323-1326.
24. Daston, M.M., and Ratner, N. (1992). Neurofibromin, a predominantly neuronal GTPase activating protein in the adult, is ubiquitously expressed during development. Dev. Dyn. 195, 216-226.
25. De Schepper, S., Boucneau, J., Lambert, J., Messiaen, L., and Naeyaert, J.M. (2005). Pigment cell-related manifestations in neurofibromatosis type 1: an overview. Pigment Cell Res. 18, 13-24.
26. De Schepper, S., Maertens, O., Callens, T., Naeyaert, J.M., Lambert, J., and Messiaen, L. (2008). Somatic mutation analysis in NF1 cafe au lait spots reveals two NF1 hits in the melanocytes. J. Invest. Dermatol. 128, 1050-1053.
27. Deo, M., Huang, J.L., Fuchs, H., De Angelis, M.H., and Van Raamsdonk, C.D. (2013). Differential effects of neurofibromin gene dosage on melanocyte development. J. Invest. Dermatol. 133, 49-58.
28. Doddrell, R.D., Dun, X.P., Moate, R.M., Jessen, K.R., Mirsky, R., and Parkinson, D.B. (2012). Regulation of Schwann cell differentiation and proliferation by the Pax-3 transcription factor. Glia 60, 1269-1278.
29. Doddrell, R.D., Dun, X.P., Shivane, A., Feltri, M.L., Wrabetz, L., Wegner, M., Sock, E., Hanemann, C.O., and Parkinson, D.B. (2013). Loss of SOX10 function contributes to the phenotype of human Merlin-null schwannoma cells. Brain 136, 549-563.
30. Dottori, M., Gross, M.K., Labosky, P., and Goulding, M. (2001). The winged-helix transcription factor Foxd3 suppresses interneuron differentiation and promotes neural crest cell fate. Development 128, 4127-4138.
31. Ernfors, P. (2010). Cellular origin and developmental mechanisms during the formation of skin melanocytes. Exp. Cell Res. 316, 1397-1407.
32. Feltri, M.L., D'antonio, M., Previtali, S., Fasolini, M., Messing, A., and Wrabetz, L. (1999). P0-Cre transgenic mice for inactivation of adhesion molecules in Schwann cells. Ann. N. Y. Acad. Sci. 883, 116-123.
33. Ferguson, K.M., Darling, P.J., Mohan, M.J., Macatee, T.L., and Lemmon, M.A. (2000). Extracellular domains drive homo- but not hetero-dimerization of erbB receptors. EMBO J. 19, 4632-4643.
34. Fetsch, J.F., Michal, M., and Miettinen, M. (2000). Pigmented (melanotic) neurofibroma: a clinicopathologic and immunohistochemical analysis of 19 lesions from 17 patients. Am. J. Surg. Pathol. 24, 331-343.
35. Finzsch, M., Schreiner, S., Kichko, T., Reeh, P., Tamm, E.R., Bosl, M.R., Meijer, D., and Wegner, M. (2010). Sox10 is required for Schwann cell identity and progression beyond the immature Schwann cell stage. J. Cell Biol. 189, 701-712.
36. Fitch, K.R., McGowan, K.A., Van Raamsdonk, C.D., Fuchs, H., Lee, D., Puech, A., Herault, Y., Threadgill, D.W., Hrabe De Angelis, M., and Barsh, G.S. (2003). Genetics of dark skin in mice. Genes Dev. 17, 214-228.
37. Fleck, D., Garratt, A.N., Haass, C., and Willem, M. (2012). BACE1 dependent neuregulin processing: review. Curr. Alzheimer Res. 9, 178-183.
38. Font, R.L., and Truong, L.D. (1984). Melanotic schwannoma of soft tissues. Electron-microscopic observations and review of literature. Am. J. Surg. Pathol. 8, 129-138.
39. Fountain, J.W., Wallace, M.R., Bruce, M.A., Seizinger, B.R., Menon, A.G., Gusella, J.F., Michels, V.V., Schmidt, M.A., Dewald, G.W., and Collins, F.S. (1989). Physical mapping of a translocation breakpoint in neurofibromatosis. Science 244, 1085-1087.
40. Franz, T. (1990). Defective ensheathment of motoric nerves in the Splotch mutant mouse. Acta Anat. (Basel) 138, 246-253.
41. Fricker, F.R., and Bennett, D.L. (2011). The role of neuregulin-1 in the response to nerve injury. Future Neurol. 6, 809-822.
42. Fricker, F.R., Lago, N., Balarajah, S. et al. (2011). Axonally derived neuregulin-1 is required for remyelination and regeneration after nerve injury in adulthood. J. Neurosci. 31, 3225-3233.
43. Fullen, D.R., Reed, J.A., Finnerty, B., and McNutt, N.S. (2001). S100A6 preferentially labels type C nevus cells and nevic corpuscles: additional support for Schwannian differentiation of intradermal nevi. J. Cutan. Pathol. 28, 393-399.
44. Gambardella, L., Schneider-Maunoury, S., Voiculescu, O., Charnay, P., and Barrandon, Y. (2000). Pattern of expression of the transcription factor Krox-20 in mouse hair follicle. Mech. Dev. 96, 215-218.
45. Garcia, R.I., and Szabo, G. (1979). Melanosomes in dermal Schwann cells of human and rodent skin. Arch. Dermatol. Res. 264, 83-87.
46. Goding, C.R. (2000). Mitf from neural crest to melanoma: signal transduction and transcription in the melanocyte lineage. Genes Dev. 14, 1712-1728.
47. Gordon-Thomson, C., Jones, J., Mason, R.S., and Moore, G.P. (2005). ErbB receptors mediate both migratory and proliferative activities in human melanocytes and melanoma cells. Melanoma Res. 15, 21-28.
48. Goulding, M.D., Chalepakis, G., Deutsch, U., Erselius, J.R., and Gruss, P. (1991). Pax-3, a novel murine DNA binding protein expressed during early neurogenesis. EMBO J. 10, 1135-1147.
49. Greenhill, E.R., Rocco, A., Vibert, L., Nikaido, M., and Kelsh, R.N. (2011). An iterative genetic and dynamical modelling approach identifies novel features of the gene regulatory network underlying melanocyte development. PLoS Genet. 7, e1002265.
50. Gutzmer, R., Herbst, R.A., Mommert, S., Kiehl, P., Matiaske, F., Rutten, A., Kapp, A., and Weiss, J. (2000). Allelic loss at the neurofibromatosis type 1 (NF1) gene locus is frequent in desmoplastic neurotropic melanoma. Hum. Genet. 107, 357-361.
51. Hari, L., Miescher, I., Shakhova, O., Suter, U., Chin, L., Taketo, M., Richardson, W.D., Kessaris, N., and Sommer, L. (2012). Temporal control of neural crest lineage generation by Wnt/beta-catenin signaling. Development 139, 2107-2117.
52. He, Y., Kim, J.Y., Dupree, J., Tewari, A., Melendez-Vasquez, C., Svaren, J., and Casaccia, P. (2010). Yy1 as a molecular link between neuregulin and transcriptional modulation of peripheral myelination. Nat. Neurosci. 13, 1472-1480.
53. Heermann, S., and Schwab, M.H. (2013). Molecular control of Schwann cell migration along peripheral axons: keep moving!. Cell Adh. Migr. 7, 18-22.
54. Hochgreb-Hagele, T., and Bronner, M.E. (2013). A novel FoxD3 gene trap line reveals neural crest precursor movement and a role for FoxD3 in their specification. Dev. Biol. 374, 1-11.
55. Hornyak, T.J., Hayes, D.J., Chiu, L.Y., and Ziff, E.B. (2001). Transcription factors in melanocyte development: distinct roles for Pax-3 and Mitf. Mech. Dev. 101, 47-59.
56. Hultman, K.A., Budi, E.H., Teasley, D.C., Gottlieb, A.Y., Parichy, D.M., and Johnson, S.L. (2009). Defects in ErbB-dependent establishment of adult melanocyte stem cells reveal independent origins for embryonic and regeneration melanocytes. PLoS Genet. 5, e1000544.
57. Huttenbach, Y., Prieto, V.G., and Reed, J.A. (2002). Desmoplastic and spindle cell melanomas express protein markers of the neural crest but not of later committed stages of Schwann cell differentiation. J. Cutan. Pathol. 29, 562-568.
58. Jaegle, M., Ghazvini, M., Mandemakers, W., Piirsoo, M., Driegen, S., Levavasseur, F., Raghoenath, S., Grosveld, F., and Meijer, D. (2003). The POU proteins Brn-2 and Oct-6 share important functions in Schwann cell development. Genes Dev. 17, 1380-1391.
59. Jaimes, N., Chen, L., Dusza, S.W. et al. (2013). Clinical and dermoscopic characteristics of desmoplastic melanomas. JAMA Dermatol. 149, 413-421.
60. Jessen, K.R., and Mirsky, R. (2005). The origin and development of glial cells in peripheral nerves. Nat. Rev. Neurosci. 6, 671-682.
61. Jones, E.A., Lopez-Anido, C., Srinivasan, R., Krueger, C., Chang, L.W., Nagarajan, R., and Svaren, J. (2011). Regulation of the PMP22 gene through an intronic enhancer. J. Neurosci. 31, 4242-4250.
62. Kao, S.C., Wu, H., Xie, J., Chang, C.P., Ranish, J.A., Graef, I.A., and Crabtree, G.R. (2009). Calcineurin/NFAT signaling is required for neuregulin-regulated Schwann cell differentiation. Science 323, 651-654.
63. Kazmi, S.J., Byer, S.J., Eckert, J.M., Turk, A.N., Huijbregts, R.P., Brossier, N.M., Grizzle, W.E., Mikhail, F.M., Roth, K.A., and Carroll, S.L. (2013). Transgenic mice overexpressing neuregulin-1 model neurofibroma-malignant peripheral nerve sheath tumor progression and implicate specific chromosomal copy number variations in tumorigenesis. Am. J. Pathol. 182, 646-667.
64. Kim, C., Cheng, C.Y., Saldanha, S.A., and Taylor, S.S. (2007). PKA-I holoenzyme structure reveals a mechanism for cAMP-dependent activation. Cell 130, 1032-1043.
65. Kioussi, C., Gross, M.K., and Gruss, P. (1995). Pax3: a paired domain gene as a regulator in PNS myelination. Neuron 15, 553-562.
66. Kirschner, L.S., Carney, J.A., Pack, S.D., Taymans, S.E., Giatzakis, C., Cho, Y.S., Cho-Chung, Y.S., and Stratakis, C.A. (2000). Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex. Nat. Genet. 26, 89-92.
67. Kos, R., Reedy, M.V., Johnson, R.L., and Erickson, C.A. (2001). The winged-helix transcription factor FoxD3 is important for establishing the neural crest lineage and repressing melanogenesis in avian embryos. Development 128, 1467-1479.
68. Kusters-Vandevelde, H.V., Van Engen-Van Grunsven, I.A., Kusters, B., Van Dijk, M.R., Groenen, P.J., Wesseling, P., and Blokx, W.A. (2010). Improved discrimination of melanotic schwannoma from melanocytic lesions by combined morphological and GNAQ mutational analysis. Acta Neuropathol. 120, 755-764.
69. La Marca, R., Cerri, F., Horiuchi, K., Bachi, A., Feltri, M.L., Wrabetz, L., Blobel, C.P., Quattrini, A., Salzer, J.L., and Taveggia, C. (2011). TACE (ADAM17) inhibits Schwann cell myelination. Nat. Neurosci. 14, 857-865.
70. Labosky, P.A., and Kaestner, K.H. (1998). The winged helix transcription factor Hfh2 is expressed in neural crest and spinal cord during mouse development. Mech. Dev. 76, 185-190.
71. Lang, D., Lu, M.M., Huang, L., Engleka, K.A., Zhang, M., Chu, E.Y., Lipner, S., Skoultchi, A., Millar, S.E., and Epstein, J.A. (2005). Pax3 functions at a nodal point in melanocyte stem cell differentiation. Nature 433, 884-887.
72. Le Douarin, N.M., and Dupin, E. (2003). Multipotentiality of the neural crest. Curr. Opin. Genet. Dev. 13, 529-536.
73. Le, N., Nagarajan, R., Wang, J.Y., Araki, T., Schmidt, R.E., and Milbrandt, J. (2005). Analysis of congenital hypomyelinating Egr2Lo/Lo nerves identifies Sox2 as an inhibitor of Schwann cell differentiation and myelination. Proc. Natl Acad. Sci. USA 102, 2596-2601.
74. Le, L.Q., Liu, C., Shipman, T., Chen, Z., Suter, U., and Parada, L.F. (2011). Susceptible stages in Schwann cells for NF1-associated plexiform neurofibroma development. Cancer Res. 71, 4686-4695.
75. Levi, A.D., Bunge, R.P., Lofgren, J.A., Meima, L., Hefti, F., Nikolics, K., and Sliwkowski, M.X. (1995). The influence of heregulins on human Schwann cell proliferation. J. Neurosci. 15, 1329-1340.
76. Luo, X., Prior, M., He, W. et al. (2011). Cleavage of neuregulin-1 by BACE1 or ADAM10 protein produces differential effects on myelination. J. Biol. Chem. 286, 23967-23974.
77. Lyons, D.A., Pogoda, H.M., Voas, M.G., Woods, I.G., Diamond, B., Nix, R., Arana, N., Jacobs, J., and Talbot, W.S. (2005). erbb3 and erbb2 are essential for schwann cell migration and myelination in zebrafish. Curr. Biol. 15, 513-524.
78. Mackenzie, M.A., Jordan, S.A., Budd, P.S., and Jackson, I.J. (1997). Activation of the receptor tyrosine kinase Kit is required for the proliferation of melanoblasts in the mouse embryo. Dev. Biol. 192, 99-107.
79. Maertens, O., Brems, H., Vandesompele, J. et al. (2006). Comprehensive NF1 screening on cultured Schwann cells from neurofibromas. Hum. Mutat. 27, 1030-1040.
80. Maertens, O., De Schepper, S., Vandesompele, J., Brems, H., Heyns, I., Janssens, S., Speleman, F., Legius, E., and Messiaen, L. (2007). Molecular dissection of isolated disease features in mosaic neurofibromatosis type 1. Am. J. Hum. Genet. 81, 243-251.
81. Masaki, T., Qu, J., Cholewa-Waclaw, J., Burr, K., Raaum, R., and Rambukkana, A. (2013). Reprogramming adult Schwann cells to stem cell-like cells by leprosy bacilli promotes dissemination of infection. Cell 152, 51-67.
82. Maurel, P., and Salzer, J.L. (2000). Axonal regulation of Schwann cell proliferation and survival and the initial events of myelination requires PI 3-kinase activity. J. Neurosci. 20, 4635-4645.
83. Mayes, D.A., Rizvi, T.A., Cancelas, J.A., Kolasinski, N.T., Ciraolo, G.M., Stemmer-Rachamimov, A.O., and Ratner, N. (2011). Perinatal or adult Nf1 inactivation using tamoxifen-inducible PlpCre each cause neurofibroma formation. Cancer Res. 71, 4675-4685.
84. McClatchey, A.I. (2007). Neurofibromatosis. Annu. Rev. Pathol. 2, 191-216.
85. Meintanis, S., Thomaidou, D., Jessen, K.R., Mirsky, R., and Matsas, R. (2001). The neuron-glia signal beta-neuregulin promotes Schwann cell motility via the MAPK pathway. Glia 34, 39-51.
86. Meyer, D., and Birchmeier, C. (1995). Multiple essential functions of neuregulin in development. Nature 378, 386-390.
87. Michailov, G.V., Sereda, M.W., Brinkmann, B.G., Fischer, T.M., Haug, B., Birchmeier, C., Role, L., Lai, C., Schwab, M.H., and Nave, K.A. (2004). Axonal neuregulin-1 regulates myelin sheath thickness. Science 304, 700-703.
88. Michalski, J.P., Anderson, C., Beauvais, A., De Repentigny, Y., and Kothary, R. (2011). The proteolipid protein promoter drives expression outside of the oligodendrocyte lineage during embryonic and early postnatal development. PLoS ONE 6, e19772.
89. Miller, D.D., Emley, A., Yang, S., Richards, J.E., Lee, J.E., Deng, A., Hoang, M.P., and Mahalingam, M. (2012). Mixed versus pure variants of desmoplastic melanoma: a genetic and immunohistochemical appraisal. Mod. Pathol. 25, 505-515.
90. Mohamed, A., Gonzalez, R.S., Lawson, D., Wang, J., and Cohen, C. (2013). SOX10 expression in malignant melanoma, carcinoma, and normal tissues. Appl. Immunohistochem. Mol. Morphol. (in press).
91. Murali, R., Field, A.S., McKenzie, P.R., McLeod, D.J., Stretch, J.R., Thompson, J.F., and Scolyer, R.A. (2010). Melanotic schwannoma mimicking metastatic pigmented melanoma: a pitfall in cytological diagnosis. Pathology 42, 287-289.
92. Napoli, I., Noon, L.A., Ribeiro, S. et al. (2012). A central role for the ERK-signaling pathway in controlling Schwann cell plasticity and peripheral nerve regeneration in vivo. Neuron 73, 729-742.
93. Newbern, J., and Birchmeier, C. (2010). Nrg1/ErbB signaling networks in Schwann cell development and myelination. Semin. Cell Dev. Biol. 21, 922-928.
94. Newbern, J.M., and Snider, W.D. (2012). Bers-ERK Schwann cells coordinate nerve regeneration. Neuron 73, 623-626.
95. Newbern, J.M., Li, X., Shoemaker, S.E. et al. (2011). Specific functions for ERK/MAPK signaling during PNS development. Neuron 69, 91-105.
96. Nishimura, E.K., Jordan, S.A., Oshima, H., Yoshida, H., Osawa, M., Moriyama, M., Jackson, I.J., Barrandon, Y., Miyachi, Y., and Nishikawa, S. (2002). Dominant role of the niche in melanocyte stem-cell fate determination. Nature 416, 854-860.
97. Orchard, G.E. (2000). Comparison of immunohistochemical labelling of melanocyte differentiation antibodies melan-A, tyrosinase and HMB 45 with NKIC3 and S100 protein in the evaluation of benign naevi and malignant melanoma. Histochem. J. 32, 475-481.
98. Palla, B., Su, A., Binder, S., and Dry, S. (2013). SOX10 expression distinguishes desmoplastic melanoma from its histologic mimics. Am. J. Dermatopathol. 35, 576-581.
99. Parmantier, E., Lynn, B., Lawson, D., Turmaine, M., Namini, S.S., Chakrabarti, L., McMahon, A.P., Jessen, K.R., and Mirsky, R. (1999). Schwann cell-derived Desert hedgehog controls the development of peripheral nerve sheaths. Neuron 23, 713-724.
100. Parrinello, S., Napoli, I., Ribeiro, S., Wingfield Digby, P., Fedorova, M., Parkinson, D.B., Doddrell, R.D., Nakayama, M., Adams, R.H., and Lloyd, A.C. (2010). EphB signaling directs peripheral nerve regeneration through Sox2-dependent Schwann cell sorting. Cell 143, 145-155.
101. Penneys, N.S., Mogollon, R., Kowalczyk, A., Nadji, M., and Adachi, K. (1984). A survey of cutaneous neural lesions for the presence of myelin basic protein. An immunohistochemical study. Arch. Dermatol. 120, 210-213.
102. Perlin, J.R., Lush, M.E., Stephens, W.Z., Piotrowski, T., and Talbot, W.S. (2011). Neuronal Neuregulin 1 type III directs Schwann cell migration. Development 138, 4639-4648.
103. Potterf, S.B., Furumura, M., Dunn, K.J., Arnheiter, H., and Pavan, W.J. (2000). Transcription factor hierarchy in Waardenburg syndrome: regulation of MITF expression by SOX10 and PAX3. Hum. Genet. 107, 1-6.
104. Raphael, A.R., Lyons, D.A., and Talbot, W.S. (2011). ErbB signaling has a role in radial sorting independent of Schwann cell number. Glia 59, 1047-1055.
105. Rawles, M.E. (1947). Origin of pigment cells from the neural crest in the mouse embryo. Physiol. Zool. 20, 248-266.
106. Reed, J.A., Finnerty, B., and Albino, A.P. (1999). Divergent cellular differentiation pathways during the invasive stage of cutaneous malignant melanoma progression. Am. J. Pathol. 155, 549-555.
107. Riethmacher, D., Sonnenberg-Riethmacher, E., Brinkmann, V., Yamaai, T., Lewin, G.R., and Birchmeier, C. (1997). Severe neuropathies in mice with targeted mutations in the ErbB3 receptor. Nature, 389, 725-730.
108. Rizvi, T.A., Huang, Y., Sidani, A., Atit, R., Largaespada, D.A., Boissy, R.E., and Ratner, N. (2002). A novel cytokine pathway suppresses glial cell melanogenesis after injury to adult nerve. J. Neurosci. 22, 9831-9840.
109. Roh, E., Yun, C.Y., Young Yun, J. et al. (2013). cAMP-binding site of PKA as a molecular target of bisabolangelone against melanocyte-specific hyperpigmented disorder. J. Invest. Dermatol. 133, 1072-1079.
110. Saavedra, E., Singh, A.D., Sears, J.E., and Ratliff, N.B. (2006). Plexiform pigmented schwannoma of the uvea. Surv. Ophthalmol. 51, 162-168.
111. Shakhova, O., Zingg, D., Schaefer, S.M. et al. (2012). Sox10 promotes the formation and maintenance of giant congenital naevi and melanoma. Nat. Cell Biol. 14, 882-890.
112. Shields, L.B., Glassman, S.D., Raque, G.H., and Shields, C.B. (2011). Malignant psammomatous melanotic schwannoma of the spine: a component of Carney complex. Surg. Neurol. Int. 2, 136.
113. Stassart, R.M., Fledrich, R., Velanac, V., Brinkmann, B.G., Schwab, M.H., Meijer, D., Sereda, M.W., and Nave, K.A. (2013). A role for Schwann cell-derived neuregulin-1 in remyelination. Nat. Neurosci. 16, 48-54.
114. Stonecypher, M.S., Chaudhury, A.R., Byer, S.J., and Carroll, S.L. (2006). Neuregulin growth factors and their ErbB receptors form a potential signaling network for schwannoma tumorigenesis. J. Neuropathol. Exp. Neurol. 65, 162-175.
115. Teng, L., Mundell, N.A., Frist, A.Y., Wang, Q., and Labosky, P.A. (2008). Requirement for Foxd3 in the maintenance of neural crest progenitors. Development 135, 1615-1624.
116. Thomas, A.J., and Erickson, C.A. (2009). FOXD3 regulates the lineage switch between neural crest-derived glial cells and pigment cells by repressing MITF through a non-canonical mechanism. Development 136, 1849-1858.
117. Topilko, P., Schneider-Maunoury, S., Levi, G., Baron-Van Evercooren, A., Chennoufi, A.B., Seitanidou, T., Babinet, C., and Charnay, P. (1994). Krox-20 controls myelination in the peripheral nervous system. Nature 371, 796-799.
118. Van Raamsdonk, C.D., Bezrookove, V., Green, G., Bauer, J., Gaugler, L., O'Brien, J.M., Simpson, E.M., Barsh, G.S., and Bastian, B.C. (2009). Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi. Nature 457, 599-602.
119. Veugelers, M., Wilkes, D., Burton, K. et al. (2004). Comparative PRKAR1A genotype-phenotype analyses in humans with Carney complex and prkar1a haploinsufficient mice. Proc. Natl Acad. Sci. USA 101, 14222-14227.
120. Voiculescu, O., Charnay, P., and Schneider-Maunoury, S. (2000). Expression pattern of a Krox-20/Cre knock-in allele in the developing hindbrain, bones, and peripheral nervous system. Genesis 26, 123-126.
121. Wallace, M.R., Marchuk, D.A., Andersen, L.B. et al. (1990). Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients. Science 249, 181-186.
122. Wilkes, D., McDermott, D.A., and Basson, C.T. (2005). Clinical phenotypes and molecular genetic mechanisms of Carney complex. Lancet Oncol. 6, 501-508.
123. Wong, C.E., Paratore, C., Dours-Zimmermann, M.T. et al. (2006). Neural crest-derived cells with stem cell features can be traced back to multiple lineages in the adult skin. J. Cell Biol. 175, 1005-1015.
124. Woodhoo, A., and Sommer, L. (2008). Development of the Schwann cell lineage: from the neural crest to the myelinated nerve. Glia 56, 1481-1490.
125. Wu, J., Williams, J.P., Rizvi, T.A., Kordich, J.J., Witte, D., Meijer, D., Stemmer-Rachamimov, A.O., Cancelas, J.A., and Ratner, N. (2008). Plexiform and dermal neurofibromas and pigmentation are caused by Nf1 loss in desert hedgehog-expressing cells. Cancer Cell 13, 105-116.
126. Yang, F.C., Ingram, D.A., Chen, S. et al. (2003). Neurofibromin-deficient Schwann cells secrete a potent migratory stimulus for Nf1+/- mast cells. J. Clin. Invest. 112, 1851-1861.
127. Yang, F.C., Chen, S., Clegg, T. et al. (2006). Nf1+/- mast cells induce neurofibroma like phenotypes through secreted TGF-beta signaling. Hum. Mol. Genet. 15, 2421-2437.
128. Yang, F.C., Ingram, D.A., Chen, S. et al. (2008). Nf1-dependent tumors require a microenvironment containing Nf1+/- and c-kit-dependent bone marrow. Cell 135, 437-448.
129. Yoshimura, N., Motohashi, T., Aoki, H., Tezuka, K., Watanabe, N., Wakaoka, T., Era, T., and Kunisada, T. (2013). Dual origin of melanocytes defined by Sox1 expression and their region-specific distribution in mammalian skin. Dev. Growth Differ. 55, 270-281.
130. Zembowicz, A., Knoepp, S.M., Bei, T., Stergiopoulos, S., Eng, C., Mihm, M.C., and Stratakis, C.A. (2007). Loss of expression of protein kinase a regulatory subunit 1alpha in pigmented epithelioid melanocytoma but not in melanoma or other melanocytic lesions. Am. J. Surg. Pathol. 31, 1764-1775.
131. Zhu, Y., Ghosh, P., Charnay, P., Burns, D.K., and Parada, L.F. (2002). Neurofibromas in NF1: Schwann cell origin and role of tumor environment. Science 296, 920-922.